1. Ayanoglu, G., A new aspect of serum protein binding of tolbutamide.Int. J. Clin. Pharmcol. Ther. Toxicol., 24(2), 65–68 (1986).
2. Adir, J., Effects of total plasma concentration and age on tolbutamide plasma protein binding.Clin. Pharmcol. Ther., 31(4), 488–493 (1982).
3. Balant, L. P., Dayer, P., and Faber, J., Consequences of renal insufficiency on the hepatic clearance of some drugs.Int. J. Clin. Pharmacol. Res., 3, 459–474 (1983).
4. Beck-Nielsen, H., Hjllund, E., and Sorensen, N. S., Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.Diabetes Care, 7(Suppl1), 100–105 (1984).
5. Belandger, P. M., The characteristics of the microsomal hydroxylation of tolbutamide.Can. J. Physiol. Pharmacol., 69(3), 400–405 (1991).